THBD and COVID-19: It has been observed that severely ill patients had a higher risk of coagulopathy and increased amounts of factor V. Changes in COVID-19 include changes in the PROS1 and THBD genes, the expressions of which are reduced in the course of infection, which also adversely affects the formation of thrombotic complications [78,90,94].